إعلان
إعلان

INSP

INSP logo

Inspire Medical Systems, Inc.

92.20
USD
برعاية
-0.37
-0.40%
٣١ ديسمبر, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

92.20

0.00
0.00%

تقارير أرباح INSP

النسبة الإيجابية المفاجئة

INSP تفوق 29 من 31 آخر التقديرات.

94%

التقرير التالي

بيانات التقرير القادم
٠٩ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$267.98M
/
$0.67
التغير الضمني من Q3 25 (Revenue/ EPS)
+19.37%
/
+97.06%
التغير الضمني من Q4 24 (Revenue/ EPS)
+11.79%
/
-41.23%

Inspire Medical Systems, Inc. earnings per share and revenue

On ٠٣ نوفمبر ٢٠٢٥, INSP reported earnings of 0.34 USD per share (EPS) for Q3 25, beating the estimate of -0.19 USD, resulting in a 271.72% surprise. Revenue reached 224.50 مليون, compared to an expected 224.88 مليون, with a -0.17% difference. The market reacted with a +15.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 19 analysts forecast an EPS of 0.67 USD, with revenue projected to reach 267.98 مليون USD, implying an increase of 97.06% EPS, and increase of 19.37% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Inspire Medical Systems, Inc. reported EPS of $0.34, beating estimates by 271.72%, and revenue of $224.50M, -0.17% below expectations.
The stock price moved up 15.33%, changed from $73.71 before the earnings release to $85.01 the day after.
The next earning report is scheduled for ٠٩ فبراير ٢٠٢٦.
Based on 19 analysts, Inspire Medical Systems, Inc. is expected to report EPS of $0.67 and revenue of $267.98M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان